SCHEDULE OF WARRANT ACTIVITY (Details) - Warrant [Member] - $ / shares shares in Thousands |
6 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2026 |
Sep. 30, 2025 |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
| Number of Warrants, Outstanding Beginning | 832 | |
| Weighted Average Exercise Price, Outstanding Beginning | $ 17.40 | |
| Weighted Average Remaining Life | 2 years 8 months 23 days | 2 years 10 months 20 days |
| Number of Warrants, Granted | ||
| Weighted Average Exercise Price, Granted | ||
| Number of Warrants, Exercised | ||
| Weighted Average Exercise Price, Exercised | ||
| Number of Warrants, Canceled/Forfeited | (101) | |
| Weighted Average Exercise Price, Canceled/Forfeited | $ (18.72) | |
| Number of Warrants, Outstanding Ending | 731 | 832 |
| Weighted Average Exercise Price, Outstanding Ending | $ 17.22 | $ 17.40 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercised weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments forfeitures weighted average grant date fair value. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average grant date fair value. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments weighted average grant date fair value. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments weighted average remaining contractual terms. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|